Adam Belley Selected Research

Adam Belley Research Topics

12	Infections 10/2022 - 10/2008
4	Urinary Tract Infections (Urinary Tract Infection) 01/2023 - 01/2019
3	Pyelonephritis 01/2023 - 01/2020
2	Body Weight (Weight, Body) 01/2020 - 01/2013
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023
1	Pneumonia (Pneumonitis) 01/2020
1	Healthcare-Associated Pneumonia 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Activated Protein C Resistance (APC Resistance) 01/2017
1	Persistent Infection 01/2016

9	oritavancinIBA 01/2018 - 10/2008
7	LipoglycopeptidesIBA 01/2018 - 10/2008
6	Cefepime (Maxipime)FDA LinkGeneric 01/2023 - 01/2019
6	enmetazobactamIBA 01/2023 - 01/2019
4	Daptomycin FDA Link 01/2018 - 06/2009
4	Vancomycin FDA LinkGeneric 01/2018 - 06/2009
2	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2023 - 10/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2016
2	dalbavancinIBA 02/2017 - 01/2016
1	Surface-Active Agents (Surfactants)IBA 01/2023
1	LactamsIBA 10/2022
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2021
1	beta-Lactamase InhibitorsIBA 01/2020
1	LipopeptidesIBA 01/2018
1	Ceftaroline FDA Link 02/2017
1	telavancin FDA Link 02/2017
1	tedizolidIBA 02/2017
1	Factor Xa (Coagulation Factor Xa)IBA 01/2017
1	Heparin (Liquaemin)FDA LinkGeneric 01/2017
1	Linezolid (Zyvox)FDA Link 06/2009
1	TeicoplaninIBA 06/2009

2	Therapeutics 10/2022 - 01/2018